Trial Profile
A randomized, multicenter, double-blind, parallel-design, phase 2 trial of oral MD-1100 acetate [linaclotide] administered for 14 days once daily at 100 microg, 300 microgg, 1000 microg, or placebo to patients with chronic constipation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2006
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors Ironwood Pharmaceuticals
- 27 Oct 2006 Status change
- 08 Oct 2006 New trial record.